Blog - Page 456 of 5639 - QualityStocks

TuesdayMay 07, 2024 10:30 am

SenesTech Inc.’s (NASDAQ: SNES) Evolve(TM) Soft Bait – New York’s Answer to the Growing Rat Problem

SenesTech’s Evolve(TM) Soft Bait has been proposed to be used in New York City to control its growing rat population In a bill tabled by Upper West Side Council Member Shaun Abreu, the city will explore contraception for rats and will start with a 10-block area SenesTech’s CTO notes that the city should see close to complete elimination of the population in 12-18 months, not by just controlling the death rate, but by controlling the birth rate as well For SenesTech, this move helps affirm the superiority of its products. In addition, it serves as a sign of even bigger…

TuesdayMay 07, 2024 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting the Massive Type 2 Diabetes and Obesity Markets with its DehydraTECH(TM) Technology

Lexaria, a global innovator in drug delivery platforms, through its patented DehydraTECH(TM) technology, looks to address the growing type 2 diabetes and obesity problem Given the success of previous studies, the company is looking to double down on glucagon-like peptide 1 (“GLP-1”) studies for 2024 GLP-1 treatments are a major player in managing weight and addressing diabetes, and Lexaria’s DehydraTECH(TM) drug delivery platform has the potential of replacing painful and expensive GLP-1 injections with an effective oral delivery path The company has already received independent ethics review board approval for its GLP-1 human pilot study #2, a milestone that brings…

TuesdayMay 07, 2024 9:00 am

SuperCom Ltd. (NASDAQ: SPCB) Preparing to Deliver on $5 Million in New Sales Orders for European Electronic Monitoring Officials

The growing call for court-administered electronic monitoring services remains, as evidenced by a recent deadly Pacific Northwest domestic violence case in which a judge had previously denied a victim’s petition for requiring the suspect to wear an ankle monitor Israel-based SuperCom Ltd. has dedicated its suite of PureSecurity products to help governments economically track and monitor individuals at risk for initiating new dangerous situations The company has focused its recent efforts on the North American market, while also making inroads in Europe where it recently received over $5 million in sales orders that it will fulfill over the next few…

MondayMay 06, 2024 3:32 pm

QualityStocksNewsBreaks – Cemtrex Inc. (NASDAQ: CETX) Closes on Upsized Underwritten Public Offering Worth $10M

Cemtrex (NASDAQ: CETX), an advanced-security technology and industrial services company, has closed on a firm-commitment underwritten public offering. According to the announcement, the company will receive an estimated $10 million in gross proceeds from the offering, before standard deductions and expenses. Upsized from an original $9 million commitment, the base offering consisted of 11,764,705 common units or prefunded units; the purchase price of each common unit was $0.85, and the purchase price of each prefunded unit was $0.849. Cemtrex anticipates using the net proceeds from the offering for operations as well as to increase marketing efforts and invest in existing…

MondayMay 06, 2024 3:20 pm

QualityStocksNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces Nasdaq Delisting Notification and Appeal, ADS Ratio Change

Scinai Immunotherapeutics (NASDAQ: SCNI) is a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices business unit. The company today announced that it has received a staff determination letter on April 30, 2024, from the Listing Qualifications Department of the Nasdaq Stock Market LLC. In the letter, Nasdaq notified the company that, due to its non-compliance with the minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2), the company's American Depositary Shares (“ADSs”) would be scheduled for delisting from the Nasdaq Capital Market and would be suspended…

MondayMay 06, 2024 3:06 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Launches New Research Program to Evaluate DehydraTECH-GLP-1 Drugs

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has announced an applied research program to evaluate certain molecular characteristics of DehydraTECH processed with the glucagon-peptide 1 (“GLP-1”) drug, semaglutide, related to its mode of action and performance. According to the announcement, the research will be conducted in partnership with the National Research Council of Canada (“NRC”). “We are excited about our partnership with the NRC for the mode of action molecular characterization of DehydraTECH-GLP-1 drugs. This work program could potentially provide data to assist Lexaria’s efforts in partnering with the pharmaceutical industry for the most rapid…

MondayMay 06, 2024 12:45 pm

BizCann Expo 2024 by ZJ Events, is Coming to Latin America

Date: May 18-19, 2024Venue: Plaza Mayor, Medellin Colombia ZJ Events brings BizCann Expo to Latin America, hosting the BizCann Expo 2024 in Medellin, Colombia, May 18-19, 2024. This event promises to boost cannabis investments and offer phenomenal cannabis business avenues in the region. The BizCann Expo 2024 conference offers cannabis traders, entrepreneurs, legislators, enthusiasts, and influencers, two days of networking, innovation, business, and education on the cannabis industry. The BizCann Expo 2024 is a premier event that will connect the leading American cannabis markets for better opportunities. It will boost cannabis trade by offering a networking platform to all the…

MondayMay 06, 2024 12:00 pm

FinovateSpring: Revolutionizing the Future of the Fintech Industry

Attended by thousands of people worldwide, Finovate conferences are recognized as exclusive events, providing unmatched networking and growth opportunities within the fintech industry. Fintech leaders, entrepreneurs, innovators, senior bankers, investors and financial institutions are all invited to attend the Finovate Spring event being held on May 21-22, 2024, in Marriott Marquis San Francisco, San Francisco, CA. FinovateSpring 2024 is the much-awaited showcase of technology innovations in the financial and banking sectors. Experience the future of finance with FinovateSpring 2024, a transformational event featuring a dynamic lineup of industry leaders who will share valuable insights into the future of finance and…

MondayMay 06, 2024 11:15 am

Btab Ecommerce Group Inc. (BBTT) Signs Letter of Intent with Integrated Wellness Acquisition Corp. (NYSE: WEL), Accelerating Company Growth

Btab Ecommerce and Integrated Wellness Acquisition Corp recently signed an LOI, to initiate a business combination, aiming for a process completion during the second half of 2024 Completion of the transaction is contingent upon various factors including due diligence, regulatory approvals, and approval by both companies' boards and stockholders Btab provides online technology affordable to the small and medium size online businesses that resell Btab’s proprietary products and third party products, including product supply, marketing platforms, physical showrooms, order and product return fulfillment, and after-sales support The global e-commerce market, estimated at $8.8 trillion in 2024, is projected to reach…

MondayMay 06, 2024 10:30 am

HealthLynked Corp. (HLYK) Q4, FY2023 Financial Results; Show Bottom-line Improvements, Core Network Application Ramp-Up Expected in 2024

HealthLynked achieved significant optimization in operational expenses, resulting in a 70% reduction in net loss for the fourth quarter and highlighting a period of strategic positioning for future growth HealthLynked's full-year 2023 financial results mark technological advancements, with a focus on core technologies and profitability The company anticipates further performance improvements in the second half of 2024, positioning itself as a leader in healthcare technology HealthLynked (OTCQB: HLYK), a leader in healthcare networking and technological innovation, recently announced its financial results for the fourth quarter and full year ending December 31, 2023. HealthLynked achieved a significant 70% reduction in net…

Site Search

Company Search